We have several working groups within the Tropical Institute, the Fraunhofer Immunology, Infection and Pandemic Research and the Helmholtz Munich Unit Global Health. While at the Tropical Institute, we are focused at the conduct of GCP compliant trials, both as study center in Germany or clinical sponsor of large scale global trials of several hundreds of patients, at the Fraunhofer, we focus on the preclinical development of diagnostics, vaccines and drugs, using an continuously expanding portfolio of state of the art techniques. At Helmholtz Munich, we integrate complex data analysis, both generated through trials or through routine care to better understand the spread of infectious diseases

We have several working groups within the Tropical Institute, the Fraunhofer Institute for Immunology, Infection, and Pandemic Research, and the Helmholtz Munich Unit for Global Health. At the Tropical Institute, our focus is on conducting GCP-compliant trials, either as a study centre in Germany or as a clinical sponsor of large-scale global trials involving hundreds of patients. At Fraunhofer, we concentrate on the preclinical development of diagnostics, vaccines, and drugs, utilizing an ever-expanding portfolio of state-of-the-art techniques. At Helmholtz Munich, we integrate complex data analysis—generated both through trials and routine care—to better understand the spread of infectious diseases.